Century Therapeutics, Inc. (IPSC)
Total Valuation
IPSC has a market cap or net worth of $567.91 million. The enterprise value is $229.62 million.
| Market Cap | 567.91M |
| Enterprise Value | 229.62M |
Important Dates
The next earnings date is Thursday, August 11, 2022, before market open.
| Estimated Earnings Date | Aug 11, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
IPSC has 58.85 million shares outstanding. The number of shares has increased by 643.13% in one year.
| Shares Outstanding | 58.85M |
| Shares Change (YoY) | +643.13% |
| Shares Change (QoQ) | +76.13% |
| Owned by Insiders (%) | 36.59% |
| Owned by Institutions (%) | 60.16% |
| Float | 20.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.47 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.62, with a Debt / Equity ratio of 0.06.
| Current Ratio | 16.62 |
| Quick Ratio | 16.51 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -27.80%, which is considered low. The company has a ROIC of -32.30%.
| Return on Equity (ROE) | -27.80% |
| Return on Assets (ROA) | -23.60% |
| Return on Capital (ROIC) | -32.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$676,406 |
| Employee Count | 170 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IPSC has paid $59,000 in taxes.
| Income Tax | 59,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| Total Price Change | -64.76% |
| 50-Day Moving Average | 8.60 |
| 200-Day Moving Average | 11.79 |
| Average Volume (30 Days) | 100,231 |
Short Selling Information
The latest short interest is 3.27 million, so 5.55% of the outstanding shares have been sold short.
| Short Interest | 3.27M |
| Short % of Shares Out | 5.55% |
| Short % of Float | 16.08% |
| Short Ratio (days to cover) | 44.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | 1.06M |
| Operating Income | -114.26M |
| Pretax Income | -114.93M |
| Net Income | -114.99M |
| EBITDA | -108.67M |
| EBIT | -113.66M |
| Earnings Per Share (EPS) | -$2.57 |
Balance Sheet
The company has $362.74 million in cash and $24.45 million in debt, giving a net cash position of $338.29 million or $5.75 per share.
| Cash & Cash Equivalents | 362.74M |
| Total Debt | 24.45M |
| Net Cash | 338.29M |
| Net Cash Per Share | $5.75 |
| Book Value | 386.66M |
| Book Value Per Share | 6.57 |
| Working Capital | 343.29M |
Cash Flow
In the last 12 months, operating cash flow was $19.93 million and capital expenditures -$47.15 million, giving a free cash flow of -$27.22 million.
| Operating Cash Flow | 19.93M |
| Capital Expenditures | -47.15M |
| Free Cash Flow | -27.22M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -20.25% |
| FCF Yield | -4.79% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -643.13% |
| Shareholder Yield | -643.13% |
Analyst Forecast
The average price target for IPSC is $25.70, which is 166.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $25.70 |
| Price Target Difference | 166.32% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |